Pari.com Website Review

pari’s vision is to offer innovative products for comprehensive respiratory care. we create high-quality products for all aspects of respiratory disease therapy. pari provides numerous educational tools to help manage respiratory conditions. we are here to as*ist you with every question regarding pari. we've been pioneering healthcare improvements for over 100 years, and have built a reputation for delivering innovation and quality. guided by a world-clas* research lab, we develop products that continually advance the science of respiratory care. at pari we approach the future with the expertise necessary to adapt to a changing healthcare market in an effort to improve the lives of those affected by. pari pharma’s eflow® technology device, lamira™, approved as the only nebulizer system to deliver insmed’s arikayce® (amikacin. arikayce is the first and only therapy specifically indicated for the treatment of mycobacterium avium complex (mac) lung disease in ad*lt. sunovion announces lonhala™ magnair™ (glycopyrrolate) inhalation solution now available in the u.s. for the treatment of copd. lonhala magnair is the first nebulized long-acting muscarinic antagonist (lama) available for the treatment of copd in the u.s.. proqr announces positive top-line results from a phase 1b study of qr-010 in subjects with cystic fibrosis. have fun in the pari pals™ playground or the vortex® amusement park! therapists, nurses, and case managers who are involved in the management of respiratory patients. pariorder.com is our online dealer ordering system. if you are a current pari customer, sign up today to order online, check shipping